Pharmaceutical Dust Collection Update by Camfil APC Addresses Critical Containment Strategies for Oral Solid Dose Manufacturing

Jonesboro, Arkansas – June 13, 2025 – Camfil APC, a leading manufacturer of industrial dust collection systems, today announced a major pharmaceutical dust collection update addressing critical containment challenges in oral solid dose (OSD) manufacturing. The comprehensive technical resource provides pharmaceutical industry professionals with essential strategies for managing potent compound dust while ensuring regulatory compliance and operational efficiency.

Pharmaceutical Dust Collection Update Addresses Industry Challenges

The pharmaceutical dust collection update from Camfil APC specifically targets the complex air quality management requirements facing modern pharmaceutical manufacturing facilities. As the industry continues to develop increasingly potent compounds and face stricter regulatory oversight, effective dust collection strategies have become essential for maintaining worker safety, product quality, and compliance standards.

"Pharmaceutical manufacturers today face unprecedented challenges in managing airborne contaminants from potent compounds," said Tony Galvin, pharmaceutical segment manager at Camfil APC. "Our pharmaceutical dust collection update provides the technical depth and practical guidance that industry professionals need to implement effective containment solutions."

Comprehensive Coverage of OSD Manufacturing Dust Collection

The pharmaceutical dust collection update addresses critical aspects of dust management in oral solid dose manufacturing environments, including:

• Regulatory Framework Navigation: Detailed guidance on FDA, OSHA, and cGMP requirements affecting dust collection system design and validation
• Containment Technology Selection: Technical specifications for managing different Occupational Exposure Band (OEB) levels and compound classifications
• System Integration Strategies: Practical approaches for incorporating dust collection into existing pharmaceutical production lines
• Cross-Functional Decision Making: Guidance for process engineers, facilities managers, safety professionals, and quality assurance teams

Advanced Dust Collection Solutions for Pharmaceutical Applications

The pharmaceutical dust collection update features detailed technical information on Camfil APC's specialized filtration technologies designed specifically for pharmaceutical manufacturing applications:

• Gold Series Camtain Dust Collector: Engineered for high-containment applications requiring OEB 4 and OEB 5 compliance levels
• Quad Pulse Package Compact Systems: Space-efficient solutions designed for facilities with limited mechanical room availability
• Gold Series Industrial Dust Collectors: Versatile systems optimized for general pharmaceutical manufacturing applications

Each solution incorporates advanced HEPA filtration technology and specialized containment features specifically designed to meet the stringent requirements of pharmaceutical production environments.

Expert Insights for Pharmaceutical Manufacturing Teams

The pharmaceutical dust collection update draws upon Camfil APC's extensive experience in pharmaceutical manufacturing applications, providing real-world implementation examples and technical specifications. The resource addresses the specific concerns of cross-functional teams typically involved in dust collection system selection and implementation.

"Effective pharmaceutical dust collection requires understanding both the technical requirements and the operational realities of modern production environments," noted Tony Galvin, pharmaceutical segment manager at Camfil APC. "This update bridges that gap by providing practical implementation strategies backed by proven engineering principles and regulatory expertise."

Addressing Evolving Pharmaceutical Manufacturing Requirements

The pharmaceutical dust collection update reflects current industry trends including the growing complexity of active pharmaceutical ingredient (API) handling, increased demand for contract development and manufacturing organization (CDMO) services, and enhanced focus on worker protection and environmental control.

The resource specifically addresses emerging challenges in pharmaceutical manufacturing, including:

• Enhanced Potency Requirements: Strategies for managing increasingly potent compounds requiring higher containment levels
• Validation Complexity: Protocols for meeting pharmaceutical industry validation standards and documentation requirements
• Energy Efficiency: Optimizing dust collection performance while managing operational costs
• Maintenance Planning: Sustainable approaches to system maintenance and filter replacement in pharmaceutical environments

Supporting Pharmaceutical Industry Excellence

The pharmaceutical dust collection update demonstrates Camfil APC's ongoing commitment to supporting pharmaceutical manufacturing excellence through advanced air filtration technology and technical expertise. As regulatory requirements continue to evolve and compound potency increases, effective dust collection strategies remain critical for competitive pharmaceutical operations.

The update also addresses the intersection of worker safety, product quality, and regulatory compliance, providing integrated solutions that support multiple pharmaceutical manufacturing objectives simultaneously.

Comprehensive Technical Resource Availability

The complete pharmaceutical dust collection update is available immediately through Camfil APC's website at camfilapc.com/blog/pharmaceutical-dust-collection-strategies-for-oral-solid-dose-pharmaceutical-manufacturing/.

The resource includes detailed technical specifications, implementation guidance, regulatory compliance information, and case study examples specifically relevant to pharmaceutical manufacturing applications.

About Camfil APC

Camfil APC is a leading manufacturer of dust, mist, and fume collection equipment for industrial applications, with specialized expertise in pharmaceutical manufacturing air quality solutions. The company provides engineered dust collection systems for challenging industrial environments, including pharmaceutical production, chemical processing, food manufacturing, and metalworking operations.

With decades of experience in pharmaceutical applications, Camfil APC maintains comprehensive technical capabilities including system design, installation, validation support, and ongoing maintenance services. The company's pharmaceutical dust collection solutions are designed to meet the most stringent industry requirements for containment, compliance, and operational performance.

Camfil APC operates manufacturing facilities in Jonesboro, Arkansas, and provides technical support, installation, and maintenance services across North America. The company is part of the global Camfil Group, recognized worldwide for innovation in air filtration technology and commitment to clean air solutions.

For more information about Camfil APC's pharmaceutical dust collection solutions, visit camfilapc.com or contact the pharmaceutical applications team at tony.galvin@camfil.com.

Technical Contact:
Tony Galvin
Pharmaceutical Segment Manager
Camfil APC
1-612-865-9377
Tony.galvin@camfil.com

This article was originally published by Camfil:
Pharmaceutical Dust Collection: Strategies for Oral Solid Dose Pharmaceutical Manufacturing